Navigation Links
Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
Date:2/4/2009

-Preliminary Data Show Seven of 17 Evaluable Patients Achieved an Objective Tumor Response by End of Four Treatment Cycles-

TUSTIN, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported that its lead product candidate bavituximab achieved the primary efficacy endpoint in the first stage of its ongoing Phase II clinical trial in patients with non-small cell lung cancer (NSCLC). The open-label, Simon two-stage study is designed to evaluate the safety and efficacy of the combination of bavituximab with the chemotherapy drugs carboplatin and paclitaxel in NSCLC patients. Seventeen of the 21 patients enrolled in Stage A were deemed evaluable for tumor response by the end of four treatment cycles, with six patients achieving partial tumor responses and one patient achieving a complete tumor response, according to RECIST criteria. These preliminary results exceed the pre-specified benchmark criteria established for enrolling an additional 28 patients in Stage B of this trial, up to a total of 49 patients.

"We are very pleased with the promising early results from this pilot Phase II lung cancer trial and will now move forward to initiate the second stage of the study," said Steven W. King, president and CEO of Peregrine. "We are encouraged by the number of tumor responses seen at this early time point of approximately 12 weeks in patients with NSCLC, a leading cause of cancer deaths that responds poorly to current treatments. As these patients continue on treatment, we will be assessing them for further signs of anti-tumor activity, and we look forward to sharing more data from this study as patient treatment and follow-up progress."

The primary objective of the multi-center Phase II clinical trial in patients with previously untreated locally advanced or metastatic NS
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
2. Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz
3. Peregrine Pharmaceuticals Enters Into a Loan Agreement for up to $10 Million
4. Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results
5. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
6. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
7. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
8. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
9. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
11. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Inflamax scientists worked closely with internationally ... the study, which will provide critical insight into ... in the study of allergy treatments, the Environmental ... models. Although both the models are well recognized ... direct comparison between the allergic responses evoked by ...
(Date:5/21/2013)... Clear Lake, MN (PRWEB) May 21, 2013 ... all-in-one trade show display solution for sales and marketing teams ... GLM Displays describes the kit as “everything you’ll need ... The Fusion Fabric Display Kit comes with a number of ... an all-around trade booth 20 feet by 20 feet in ...
(Date:5/20/2013)... Ga. , May 20, 2013  MiMedx Group, ... manufacturer and marketer of patent protected regenerative biomaterials and ... it has secured a revolving line of credit with ... which is secured by the Company,s accounts receivable and ... through May 1, 2014.  The facility will be used ...
(Date:5/20/2013)... New York, NY (PRWEB) May 20, 2013 ... My Cleaning Products said that although bed bugs need to ... elimination process will not compromise a person's health. And so ... a guide how to get rid of bed bugs ... recommended its non-pesticide bed bug spray it called Bed Bug ...
Breaking Biology Technology:Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2
... to deliver first open source infectious disease ... management system to meet CDC mandate, ... that brings like-minded organizations,together to work on collaborative software at ... first open source, web-based infectious,disease reporting and management system., ...
... SYDNEY, Australia, May 18 /Xinhua-PRnewswire-Firstcall/ -- Specialist,Pharmaceutical ... today,announced that it has received national approval ... indicated for measuring airway hyperresponsiveness and has,been ... mutual recognition,procedure (MRP). The necessary national approvals ...
... CRVL ) fiscal year earnings release, CorVel,will be conducting a conference call that ... Eastern Time., Event: CorVel Corporation Fiscal ... Gordon ... Time, Tuesday, June 10th, 2008, Login: ...
Cached Biology Technology:Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance 2Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance 3Collaborative Software Initiative Addresses State Governments' Requirements for Meeting Infectious Disease Compliance 4Pharmaxis' Aridol Authorised for Sale in Germany 2Pharmaxis' Aridol Authorised for Sale in Germany 3CorVel Corporation Announces Earnings Release Webcast 2
(Date:5/21/2013)... way genes function without changing the underlying DNA ... of pregnant women during any trimester, potentially providing ... weeks after giving birth, and an opportunity to ... of the small study involving 52 pregnant women ... Psychiatry . , "Postpartum depression can be harmful ...
(Date:5/20/2013)... popularly known as the lungs of the planet, inhales carbon ... the air to grow parts that eventually fall to the ... plentiful rainfall. , Until recently people believed much of ... ended up deep in the ocean. University of Washington research ... carbon dioxide though left open the question of how ...
(Date:5/20/2013)... conducted at the University of Bristol and published online ... sheds light on how the brain and inner ear ... School of Earth Sciences, together with Tom Hbner from ... of 150 million year old dinosaurs. , The two ... Dysalotosaurus lettowvorbecki : a very young (juvenile) individual ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3Fossil brain teaser 2
... among his most vibrant and celebrated works, Vincent van Gogh,s ... basis has, until now, been a mystery. In a study ... of Georgia scientists reveal the mutation behind the distinctive, thick ... more than 100 years ago. The most common sunflower ...
... A DICER protein, known to produce tiny RNAs in ... according to research on Arabidopsis thaliana . ... transcribed into a useable product, requires activation via a promoter ... Science helps to show that later stages of ...
... A team of international scientists working in the central Pacific ... the past is more likely to survive it in the ... PLoS ONE , paves the way towards an important road ... scientists identify the habitats and locations where coral reefs are ...
Cached Biology News:Genetic mutation depicted in van Gogh's sunflower paintings revealed by scientists 2Plant research reveals new role for gene silencing protein 2Some corals like it hot: Heat stress may help coral reefs survive climate change 2
...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Normal human AB serum, pooled...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Biology Products: